{"id":"NCT00347360","sponsor":"GlaxoSmithKline","briefTitle":"The COREG And Lisinopril Combination Therapy In Hypertensive Subjects (COSMOS) Trial","officialTitle":"A Randomized, Double-Blind, Double-Dummy, Parallel Group, Factorial Design Trial to Assess the Efficacy and Safety of up to Six Weeks Treatment With 20mg, 40mg, or 80mg QD Doses of Carvedilol Controlled Release Formulation (COREG CR) or 10mg, 20mg, or 40mg QD Doses of Lisinopril (Zestril) or a Combination of One of the Doses of Each Medication","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-07","primaryCompletion":"2008-04","completion":"2008-04","firstPosted":"2006-07-04","resultsPosted":"2009-11-09","lastUpdate":"2016-12-26"},"enrollment":654,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Hypertension"],"interventions":[{"type":"DRUG","name":"lisinopril","otherNames":[]},{"type":"DRUG","name":"carvedilol controlled release formulation","otherNames":["lisinopril"]}],"arms":[{"label":"lisinopril","type":"EXPERIMENTAL"},{"label":"carvedilol","type":"EXPERIMENTAL"}],"summary":"This is a randomized, double-blind, double-dummy, parallel group trial employing 15 cells of a 4x4 factorial design (no placebo)to compare the hypertensive effects in patients with Stage 1 and Stage 2 hypertension of carvedilol (20, 40 or 80 mg daily) alone, lisinopril (10, 20 or 40 mg daily) alone, and all combinations of the doses.","primaryOutcome":{"measure":"Change From Baseline to Week 6 in 24 Hour (hr) Mean Diastolic Blood Pressure","timeFrame":"Baseline, Week 6.","effectByArm":[{"arm":"Lisinopril 10","deltaMin":-5.79,"sd":5.922},{"arm":"Lisinopril 20","deltaMin":-8.11,"sd":8.811},{"arm":"Lisinopril 40","deltaMin":-7.37,"sd":5.914},{"arm":"Carvedilol Controlled Release 20","deltaMin":-4.4,"sd":5.182},{"arm":"Carvedilol Controlled Release 40","deltaMin":-7.61,"sd":4.88},{"arm":"Carvedilol Controlled Release 80","deltaMin":-6.52,"sd":6.408},{"arm":"Carvedilol Controlled Release 20 Lisinopril 10","deltaMin":-9.29,"sd":7.226},{"arm":"Carvedilol Controlled Release 20 Lisinopril 20","deltaMin":-8.57,"sd":6.585},{"arm":"Carvedilol Controlled Release 20 Lisinopril 40","deltaMin":-10.19,"sd":6.899},{"arm":"Carvedilol Controlled Release 40 Lisinopril 10","deltaMin":-9.36,"sd":7.426},{"arm":"Carvedilol Controlled Release 40 Lisinopril 20","deltaMin":-10.96,"sd":8.388},{"arm":"Carvedilol Controlled Release 40 Lisinopril 40","deltaMin":-10.37,"sd":7.234},{"arm":"Carvedilol Controlled Release 80 Lisinopril 10","deltaMin":-10.93,"sd":5.517},{"arm":"Carvedilol Controlled Release 80 Lisinopril 20","deltaMin":-11.09,"sd":8.719},{"arm":"Carvedilol Controlled Release 80 Lisinopril 40","deltaMin":-11.92,"sd":6.887}],"pValues":[{"comp":"OG000 vs OG001 vs OG002 vs OG003 vs OG004 vs OG005 vs OG006 vs OG007 vs OG008 vs OG009 vs OG010 vs OG011 vs OG012 vs OG013 vs OG014","p":">0.1"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":21},"locations":{"siteCount":151,"countries":["United States"]},"refs":{"pmids":["20883227"],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":0},"commonTop":["Headache","Dizziness","Cough","Fatigue","Nausea"]}}